EUVIMEDEUVIMED entdecken
Crossref

Targeting cancer with small-molecule pan-KRAS degraders

Johannes Popow iD, William Farnaby iD, Andreas Gollner iD, Christiane Kofink iD, Gerhard Fischer iD, Melanie Wurm iD, David Zollman iD, Andre Wijaya iD, Nikolai Mischerikow, Carina Hasenoehrl, Polina Prokofeva iD, Heribert Arnhof und 31 weitere

Science · 20.09.2024 · 385 (6715) · 1338-1347

DOI: 10.1126/science.adm8684 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 20.09.2024. Verfasst von Johannes Popow und 42 weiteren Autor:innen. Beteiligte Einrichtung: Boehringer Ingelheim RCV GmbH & Co KG, 1221 Vienna, Austria. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms, Proto-Oncogene Proteins p21(ras), Proteolysis Targeting Chimera. Die Arbeit wurde bisher 208-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mutations in the Kirsten rat sarcoma viral oncogene homolog (KRAS) protein are highly prevalent in cancer. However, small-molecule concepts that address oncogenic KRAS alleles remain elusive beyond replacing glycine at position 12 with cysteine (G12C), which is clinically drugged through covalent inhibitors. Guided by biophysical and structural studies of ternary complexes, we designed a heterobifunctional small molecule that potently degrades 13 out of 17 of the most prevalent oncogenic KRAS alleles. Compared with inhibition, KRAS degradation results in more profound and sustained pathway modulation across a broad range of KRAS mutant cell lines, killing cancer cells while sparing models without genetic KRAS aberrations. Pharmacological degradation of oncogenic KRAS was tolerated and led to tumor regression in vivo. Together, these findings unveil a new path toward addressing KRAS-driven cancers with small-molecule degraders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsNeoplasmsProto-Oncogene Proteins p21(ras)Proteolysis Targeting ChimeraAnimalsHumansMiceAllelesCell Line, TumorMutationProteolysisSmall Molecule Libraries

Substanzen

Antineoplastic AgentsKRAS protein, humanProto-Oncogene Proteins p21(ras)Small Molecule LibrariesProteolysis Targeting Chimera

Autor:innen und Institutionen

  • Boehringer Ingelheim RCV GmbH & Co KG, 1221 Vienna, Austria.
  • Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, Dundee DD1 5JJ, UK.
  • Division of Biological Chemistry and Drug Discovery, School of Life Sciences, James Black Centre, University of Dundee, Dundee DD1 5EH, UK.
  • Proteomics and Bioanalytics, School of Life Sciences, Technical University of Munich, 85354 Freising, Germany.
  • Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT 06877, USA.

ORCID-Profile: Johannes Popow, William Farnaby, Andreas Gollner, Christiane Kofink, Gerhard Fischer, Melanie Wurm, David Zollman, Andre Wijaya, Polina Prokofeva, Silvia Arce-Solano, Georg Boeck, Emelyne Diers, Aileen B Frost, Theresa Klawatsch, Manfred Koegl, Arnel A Lauber, Daniel Peter, Peggy Stolt-Bergner, Nicole Trainor, Vesna Vetma, Claire Whitworth, Jens Quant, Harald Weinstabl, Bernhard Kuster, Peter Ettmayer, Alessio Ciulli

Zitieren

APA

Popow, J., Farnaby, W., Gollner, A., Kofink, C., Fischer, G., Wurm, M., Zollman, D., Wijaya, A., Mischerikow, N., Hasenoehrl, C., Prokofeva, P., Arnhof, H., Arce-Solano, S., Bell, S., Boeck, G., Diers, E., Frost, A. B., Goodwin-Tindall, J., Karolyi-Oezguer, J., …, & Ciulli, A. (2024). Targeting cancer with small-molecule pan-KRAS degraders. Science, 385(6715), 1338-1347. https://doi.org/10.1126/science.adm8684

Vancouver

Popow J, Farnaby W, Gollner A, Kofink C, Fischer G, Wurm M, et al. Targeting cancer with small-molecule pan-KRAS degraders. Science. 2024;385(6715):1338-1347. doi:10.1126/science.adm8684

BibTeX
@article{Popow2024,
  author = {Popow, Johannes and Farnaby, William and Gollner, Andreas and Kofink, Christiane and Fischer, Gerhard and Wurm, Melanie and Zollman, David and Wijaya, Andre and Mischerikow, Nikolai and Hasenoehrl, Carina and Prokofeva, Polina and Arnhof, Heribert and Arce-Solano, Silvia and Bell, Sammy and Boeck, Georg and Diers, Emelyne and Frost, Aileen B and Goodwin-Tindall, Jake and Karolyi-Oezguer, Jale and Khan, Shakil and Klawatsch, Theresa and Koegl, Manfred and Kousek, Roland and Kratochvil, Barbara and Kropatsch, Katrin and Lauber, Arnel A and McLennan, Ross and Olt, Sabine and Peter, Daniel and Petermann, Oliver and Roessler, Vanessa and Stolt-Bergner, Peggy and Strack, Patrick and Strauss, Eva and Trainor, Nicole and Vetma, Vesna and Whitworth, Claire and Zhong, Siying and Quant, Jens and Weinstabl, Harald and Kuster, Bernhard and Ettmayer, Peter and Ciulli, Alessio},
  title = {Targeting cancer with small-molecule pan-KRAS degraders},
  journal = {Science},
  year = {2024},
  volume = {385},
  number = {6715},
  pages = {1338--1347},
  doi = {10.1126/science.adm8684}
}
Kostenlos starten →